Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate vs Saline for CI-AKI in AMI
NCT01742130Phase 4Completed
- Sponsor
- Ospedale Misericordia e Dolce
- Start
- Jan 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium bicarbonate in contrast-induced acute kidney injury (CI-AKI) (2 arms), sponsored by Ospedale Misericordia e Dolce. Primary endpoint: Incidence of contrast-induced acute kidney injury at 2 days. Started Jan 2011; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced acute kidney injury (CI-AKI)
Beyond the preview
Go deeper on NCT01742130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01742130.